X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.globenewswire.com/news-release/2024/06/05/2893669/0/en/Curium-Adds-the-Institut-Laue-Langevin-Reactor-to-Global-Irradiation-Portfolio-to-Ensure-Continuous-Supply-of-Lutetium-177-to-Benefit-More-Than-100-000-Cancer-Patients-Over-the-Nex.html
https://www.fiercepharma.com/pharma/bms-and-rayzebio-halt-radiotherapy-trial-enrollment-after-isotope-runs-scarce
https://www.globenewswire.com/news-release/2024/05/29/2889578/0/en/Curium-Extends-Irradiation-Partnership-With-NRG-I-PALLAS-in-Netherlands-for-Continuous-Supply-of-Lutetium-177-to-Treat-1-000s-of-Cancer-Patients-Each-Year.html
https://www.globenewswire.com//news-release/2024/01/04/2803911/0/en/ITM-Announces-Operational-Readiness-for-NOVA-Facility-the-World-s-Largest-Lutetium-177-Production-Site.html
https://www.prnewswire.com/news-releases/vancouver-clinic-earns-therapeutic-license-to-administer-new-drug-to-treat-prostate-cancer-301764676.html#:~:text=INITIO%20received%20the%20license%20from,Health%20Canada%20in%20September%2C%202022.
https://www.prnewswire.com/news-releases/philochem-ag-seibersdorf-labor-gmbh-and-isotopia-announce-supply-development-and-manufacturing-agreements-301701535.html
https://www.globenewswire.com/news-release/2022/10/24/2539660/0/en/ITM-Isotope-Production-System-Begins-Commercial-Production-of-Cancer-Fighting-Lutetium-177.html
https://www.prnewswire.com/news-releases/shine-technologies-submits-drug-master-file-with-the-us-food-and-drug-administration-for-non-carrier-added-lutetium-177-chloride-301596076.html
https://www.novartis.com/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer
https://www.globenewswire.com/news-release/2022/02/08/2381422/0/en/Telix-Expands-Lutetium-177-Network-with-Eckert-Ziegler-Clinical-Supply-Agreement.html
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-prostate-cancer-drug-receives-us-fda-breakthrough-designation-2021-06-16/
https://markets.businessinsider.com/news/stocks/radiopharmaceutical-cancer-treatment-lutathera-now-available-to-ontario-patients-with-midgut-neuroendocrine-tumours-nets-1029663148#
https://www.fiercepharma.com/manufacturing/novartis-plots-second-u-s-factory-to-meet-demand-for-lutathera-and-future-cancer
https://www.prnewswire.com/news-releases/nordic-nanovector-new-preclinical-data-offer-insights-into-enhancing-betalutin-based-therapies-in-nhl-300968889.html
https://www.contractpharma.com/contents/view_breaking-news/2019-10-07/nordic-nanovector-isotope-technologies-enter-supply-pact/
https://www.fiercepharma.com/pharma/zolgensma-launch-track-and-fully-line-expectation-says-novartis-ceo
Market Place
Share 
